SCHOTT Pharma AG & Co KgaA
XETRA:1SXP

Watchlist Manager
SCHOTT Pharma AG & Co KgaA Logo
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Watchlist
Price: 26.62 EUR 1.53% Market Closed
Market Cap: 4B EUR
Have any thoughts about
SCHOTT Pharma AG & Co KgaA?
Write Note

SCHOTT Pharma AG & Co KgaA
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SCHOTT Pharma AG & Co KgaA
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Long-Term Investments
€79.1m
CAGR 3-Years
17%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Evotec SE
XETRA:EVT
Long-Term Investments
€123.5m
CAGR 3-Years
-26%
CAGR 5-Years
32%
CAGR 10-Years
104%
Gerresheimer AG
XETRA:GXI
Long-Term Investments
€43.9m
CAGR 3-Years
65%
CAGR 5-Years
31%
CAGR 10-Years
16%
No Stocks Found

SCHOTT Pharma AG & Co KgaA
Glance View

Market Cap
4B EUR
Industry
Life Sciences Tools & Services

SCHOTT Pharma AG & Co KgaA is a DE-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Mainz, Hessen. The company went IPO on 2023-09-28. SCHOTT Pharma AG & Co. KGaA is a Germany-based Company, which designs advanced drug containment and drug delivery solutions for the pharmaceutical and biotech industries. The firm's product portfolio ranges from drug containment solutions to drug delivery systems manufactured in collaboration with industry partners. Its selection of pharmaceutical syringes, cartridges, vials, and ampoules is one of the widest and advanced on the market for injectable drugs.

1SXP Intrinsic Value
34.05 EUR
Undervaluation 22%
Intrinsic Value
Price

See Also

What is SCHOTT Pharma AG & Co KgaA's Long-Term Investments?
Long-Term Investments
79.1m EUR

Based on the financial report for Sep 30, 2023, SCHOTT Pharma AG & Co KgaA's Long-Term Investments amounts to 79.1m EUR.

What is SCHOTT Pharma AG & Co KgaA's Long-Term Investments growth rate?
Long-Term Investments CAGR 3Y
17%

Over the last year, the Long-Term Investments growth was -1%. The average annual Long-Term Investments growth rates for SCHOTT Pharma AG & Co KgaA have been 17% over the past three years .

Back to Top